Free Trial

DaVita (DVA) Financials

DaVita logo
$174.81 +0.25 (+0.15%)
Closing price 11/13/2026 03:59 PM Eastern
Extended Trading
$174.50 -0.31 (-0.18%)
As of 11/13/2026 07:50 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.
Annual Income Statements for DaVita

Annual Income Statements for DaVita

This table shows DaVita's income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 12/31/2015 12/31/2016 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Net Income / (Loss) Attributable to Common Shareholders
270 880 664 159 811 774 978 560 692 936 747
Consolidated Net Income / (Loss)
427 1,033 831 333 1,021 995 1,212 782 957 1,251 1,079
Net Income / (Loss) Continuing Operations
481 1,191 1,076 790 916 1,004 1,212 768 957 1,251 1,054
Total Pre-Tax Income
688 1,623 1,400 1,048 1,195 1,318 1,518 966 1,177 1,530 1,347
Total Operating Income
1,137 2,030 1,813 1,526 1,643 1,695 1,797 1,339 1,603 2,090 2,044
Total Gross Profit
3,117 3,264 3,237 3,209 3,474 3,562 3,646 3,400 3,820 4,217 4,400
Total Revenue
10,395 11,139 11,362 11,405 11,388 11,551 11,619 11,610 12,140 12,816 13,643
Operating Revenue
9,155 11,139 11,362 11,454 11,388 11,551 11,619 11,610 12,140 12,816 13,643
Total Cost of Revenue
7,278 7,875 8,125 8,196 7,914 7,989 7,972 8,210 8,320 8,599 9,243
Operating Cost of Revenue
6,856 7,432 7,640 8,196 7,914 7,989 7,972 8,210 8,320 8,599 9,243
Total Operating Expenses
1,980 1,234 1,438 1,698 1,831 1,867 1,849 2,061 2,218 2,127 2,356
Selling, General & Admin Expense
1,031 1,073 1,064 1,135 1,103 1,248 1,195 1,355 1,474 1,538 1,674
Depreciation Expense
464 509 560 591 615 630 681 733 745 724 715
Other Operating Expenses / (Income)
0.00 -374 -7.03 -7.30 0.00 16 - - -28 -26 -33
Impairment Charge
4.07 43 331 20 125 - 0.00 0.00 26 0.00 0.00
Other Special Charges / (Income)
481 -17 -524 -56 -13 -27 -27 -27 0.00 -109 0.00
Total Other Income / (Expense), net
-400 -407 -413 -477 -448 -376 -279 -373 -426 -560 -697
Interest Expense
408 414 431 487 477 393 285 357 407 490 594
Other Income / (Expense), net
8.07 7.51 18 10 29 17 6.38 -16 -19 -70 -103
Income Tax Expense
208 432 324 258 280 314 307 198 220 280 293
Net Income / (Loss) Discontinued Operations
-53 -158 -245 -457 105 -9.65 0.00 13 0.00 0.00 25
Net Income / (Loss) Attributable to Noncontrolling Interest
158 153 167 174 210 221 233 221 265 314 332
Basic Earnings per Share
$1.27 $4.36 $3.52 $0.93 $5.29 $6.46 $9.30 $6.03 $7.62 $11.02 $10.06
Weighted Average Basic Shares Outstanding
211.87M 201.64M 188.63M 170.79M 153.18M 119.80M 105.23M 92.99M 90.79M 84.99M 74.23M
Diluted Earnings per Share
$1.25 $4.29 $3.47 $0.92 $5.27 $6.31 $8.90 $5.85 $7.42 $10.73 $9.84
Weighted Average Diluted Shares Outstanding
216.25M 204.90M 191.35M 172.37M 153.81M 122.62M 109.95M 95.83M 93.18M 87.27M 75.89M
Weighted Average Basic & Diluted Shares Outstanding
212.40M 201.80M 188.50M 171.40M 125.60M 109.40M 96.30M 90.40M 87.70M 80M 66.80M

Quarterly Income Statements for DaVita

This table shows DaVita's income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026 Q2 2026 Q3 2026
Period end date 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025 9/30/2025 12/31/2025 3/31/2026 6/30/2026 9/30/2026
Net Income / (Loss) Attributable to Common Shareholders
240 223 215 259 163 199 150 234 198 265 223
Consolidated Net Income / (Loss)
306 300 296 349 232 275 240 331 275 343 269
Net Income / (Loss) Continuing Operations
306 300 296 349 232 275 240 306 275 343 269
Total Pre-Tax Income
372 371 373 414 286 369 309 383 341 435 359
Total Operating Income
484 506 535 565 439 538 506 561 482 579 499
Total Gross Profit
992 1,044 1,112 1,069 984 1,118 1,087 1,210 1,073 1,162 1,127
Total Revenue
3,071 3,187 3,264 3,295 3,224 3,380 3,420 3,620 3,416 3,554 3,578
Operating Revenue
3,071 3,187 3,264 3,295 3,224 3,380 3,420 3,620 3,416 3,554 3,578
Total Cost of Revenue
2,079 2,142 2,152 2,225 2,240 2,262 2,333 2,410 2,342 2,392 2,451
Operating Cost of Revenue
2,079 2,142 2,152 2,225 2,240 2,262 2,333 2,410 2,342 2,392 2,451
Total Operating Expenses
508 538 577 504 545 580 582 649 591 583 628
Selling, General & Admin Expense
362 368 394 414 374 413 414 472 422 423 409
Depreciation Expense
187 176 187 174 176 175 177 187 178 168 165
Impairment Charge
- - - - - - 0.00 - - - 62
Other Special Charges / (Income)
-35 0.00 0.00 -101 0.00 0.00 -10 - 0.00 0.00 -8.24
Total Other Income / (Expense), net
-112 -135 -161 -152 -153 -169 -197 -178 -141 -144 -141
Interest Expense
99 107 145 139 135 146 156 157 145 152 150
Other Income / (Expense), net
-13 -27 -17 -13 -18 -23 -41 -21 4.47 8.30 9.47
Income Tax Expense
66 72 78 64 54 94 69 77 66 92 89
Net Income / (Loss) Attributable to Noncontrolling Interest
66 77 81 90 69 76 90 97 78 78 46
Basic Earnings per Share
$2.73 $2.56 $2.56 $3.17 $2.05 $2.62 $2.09 $3.30 $2.93 $4.10 $3.49
Weighted Average Basic Shares Outstanding
87.78M 86.90M 83.72M 84.99M 79.37M 75.94M 72.08M 74.23M 67.39M 64.78M 63.84M
Diluted Earnings per Share
$2.65 $2.50 $2.50 $3.08 $2.00 $2.58 $2.04 $3.22 $2.87 $4.02 $3.40
Weighted Average Diluted Shares Outstanding
90.55M 88.95M 85.80M 87.27M 81.28M 77.36M 73.77M 75.89M 68.88M 66.09M 65.50M
Weighted Average Basic & Diluted Shares Outstanding
87.70M 83.90M 82M 80M 75.50M 71.50M 70.60M 66.80M 64.20M 63.80M 62.90M

Annual Cash Flow Statements for DaVita

This table details how cash moves in and out of DaVita's business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 12/31/2015 12/31/2016 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Net Change in Cash & Equivalents
534 -582 -218 141 371 -707 53 -216 126 415 -122
Net Cash From Operating Activities
1,557 1,972 1,913 1,772 2,072 1,979 1,931 1,565 2,059 2,022 1,887
Net Cash From Continuing Operating Activities
1,508 1,972 1,913 1,772 2,072 1,979 1,931 1,565 2,059 2,022 1,887
Net Income / (Loss) Continuing Operations
427 1,033 831 333 1,021 995 1,212 782 957 1,251 1,079
Consolidated Net Income / (Loss)
427 1,033 831 333 1,021 995 1,212 782 957 1,251 1,079
Depreciation Expense
638 720 777 591 615 630 681 733 745 724 715
Non-Cash Adjustments To Reconcile Net Income
321 -59 1,089 475 307 217 119 126 201 135 269
Changes in Operating Assets and Liabilities, net
122 278 -784 373 129 137 -80 -76 155 -88 -177
Net Cash From Investing Activities
-882 -1,202 -1,365 -1,006 2,995 -825 -785 -630 -772 -771 -655
Net Cash From Continuing Investing Activities
-882 -1,202 -1,365 -1,006 2,995 -825 -785 -627 -772 -771 -655
Purchase of Property, Plant & Equipment
-708 -829 -905 -987 -767 -675 -641 -603 -568 -555 -576
Acquisitions
-114 -591 -809 -202 -110 -204 -201 -89 -303 -251 -144
Purchase of Investments
-1,719 -1,147 -242 -14 -101 -154 -35 -131 -47 -24 -22
Divestitures
20 106 92 150 3,877 50 61 118 31 26 34
Sale and/or Maturity of Investments
1,640 1,259 499 48 102 158 31 79 115 34 54
Net Cash From Financing Activities
-139 -1,352 -766 -625 -4,696 -1,847 -1,083 -1,121 -1,170 -817 -1,375
Net Cash From Continuing Financing Activities
-139 -1,352 -766 -625 -4,696 -1,847 -1,083 -1,121 -1,170 -817 -1,375
Repayment of Debt
-53,999 -52,116 -50,837 -59,240 -40,606 -4,216 -870 -2,404 -3,091 -5,566 -4,843
Repurchase of Common Equity
-550 -1,098 -803 -1,162 -2,384 -1,458 -1,539 -802 -272 -1,386 -1,308
Payment of Dividends
-241 -214 -217 -225 -301 -261 -264 -289 -293 -391 -350
Issuance of Debt
54,542 51,991 50,992 59,935 38,526 4,047 1,615 2,393 2,468 6,624 5,612
Issuance of Common Equity
55 71 99 66 69 43 35 37 83 36 34
Other Financing Activities, net
54 13 - 0.00 0.00 -0.98 -60 -56 -65 -134 -520
Effect of Exchange Rate Changes
-2.57 - - - - -14 -10 - 8.91 -18 21

Quarterly Cash Flow Statements for DaVita

This table details how cash moves in and out of DaVita's business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026 Q2 2026 Q3 2026
Period end date 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025 9/30/2025 12/31/2025 3/31/2026 6/30/2026 9/30/2026
Net Change in Cash & Equivalents
-34 72 655 -279 -355 272 -1.55 -38 -31 25 -173
Net Cash From Operating Activities
-135 799 810 548 180 324 842 541 321 490 519
Net Cash From Continuing Operating Activities
-135 799 810 548 180 324 842 541 321 490 519
Net Income / (Loss) Continuing Operations
306 300 296 349 232 275 240 331 275 343 269
Consolidated Net Income / (Loss)
306 300 296 349 232 275 240 331 275 343 269
Depreciation Expense
187 176 187 174 176 175 177 187 178 168 165
Non-Cash Adjustments To Reconcile Net Income
16 72 81 -33 57 60 92 60 35 39 88
Changes in Operating Assets and Liabilities, net
-643 252 247 57 -286 -186 332 -37 -167 -59 -3.51
Net Cash From Investing Activities
-215 -162 -146 -248 -162 -67 -263 -163 -139 -194 -420
Net Cash From Continuing Investing Activities
-215 -162 -146 -248 -162 -67 -263 -163 -139 -194 -420
Purchase of Property, Plant & Equipment
-121 -125 -139 -171 -143 -121 -166 -145 -102 -170 -159
Acquisitions
-106 -53 -7.22 -86 -10 -2.50 -108 -24 -36 -22 -205
Purchase of Investments
-3.28 -0.44 -20 -0.36 -29 -1.11 11 -3.24 -9.95 -3.22 -83
Divestitures
7.04 5.74 5.16 7.93 11 12 9.94 1.84 3.72 0.67 12
Sale and/or Maturity of Investments
7.68 11 15 0.68 10 46 -9.59 7.41 5.38 0.05 16
Net Cash From Financing Activities
319 -563 -7.86 -565 -383 4.45 -582 -415 -213 -270 -271
Net Cash From Continuing Financing Activities
319 -563 -7.86 -565 -383 4.45 -582 -415 -213 -270 -271
Repayment of Debt
-555 -2,126 -2,803 -82 -352 -3,046 -509 -936 -920 -1,349 -763
Repurchase of Common Equity
-251 -362 -408 -365 -510 -284 -240 -274 -196 -181 -73
Payment of Dividends
-83 -65 -122 -121 -98 -58 -93 -101 -104 -65 -146
Issuance of Debt
1,290 1,985 3,348 0.68 633 3,557 482 940 1,263 1,505 743
Issuance of Common Equity
7.87 4.76 3.00 24 7.11 4.55 10 12 6.44 3.71 9.00
Other Financing Activities, net
-91 0.21 -26 -22 -62 -169 -233 -56 -263 -184 -42
Effect of Exchange Rate Changes
- -1.33 -0.65 -13 9.42 11 1.61 -0.75 0.26 -0.18 -0.19

Annual Balance Sheets for DaVita

This table presents DaVita's assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 12/31/2015 12/31/2016 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Total Assets
18,515 18,756 18,975 19,110 17,311 16,989 17,121 16,928 16,894 17,285 17,480
Total Current Assets
4,503 3,995 8,771 8,424 3,690 3,149 3,168 3,155 3,138 3,746 4,058
Cash & Equivalents
1,499 675 508 323 1,102 325 462 244 380 795 676
Restricted Cash
- - 11 92 106 177 93 95 85 85 81
Short-Term Investments
408 307 33 2.94 12 20 22 78 12 51 24
Accounts Receivable
2,160 1,792 2,114 2,328 2,285 2,369 2,385 2,546 2,410 2,530 2,909
Inventories, net
186 160 182 107 98 112 107 109 143 135 161
Prepaid Expenses
- 100 112 112 67 76 73 79 103 123 156
Current Deferred & Refundable Income Taxes
60 0.00 49 69 20 70 26 4.60 6.39 28 50
Plant, Property, & Equipment, net
2,789 2,864 3,149 3,394 3,473 3,522 3,480 3,256 3,074 2,941 2,813
Total Noncurrent Assets
11,223 11,897 7,055 7,292 10,148 10,318 10,474 10,517 10,682 10,598 10,609
Long-Term Investments
167 522 283 260 279 290 288 275 594 370 198
Goodwill
9,294 6,015 6,610 6,842 6,788 6,919 7,046 7,077 7,113 7,375 7,545
Intangible Assets
1,687 74 114 119 136 167 178 183 203 197 222
Other Noncurrent Operating Assets
74 34 47 72 2,946 2,943 2,961 2,982 2,773 2,655 2,644
Total Liabilities & Shareholders' Equity
18,515 18,756 18,975 19,110 17,311 16,989 17,121 16,928 16,894 17,285 17,480
Total Liabilities
12,567 12,933 13,077 14,077 13,812 14,092 14,751 14,703 14,150 15,194 16,322
Total Current Liabilities
2,399 2,711 3,068 4,891 2,372 2,476 2,399 2,620 2,642 2,973 3,142
Short-Term Debt
129 160 178 1,929 131 169 179 231 123 271 109
Accounts Payable
514 457 509 463 404 434 402 480 515 547 696
Current Deferred & Payable Income Tax Liabilities
- 1.39 - 0.00 42 7.77 54 18 29 10 24
Current Employee Benefit Liabilities
742 707 616 659 695 686 660 693 753 800 793
Other Current Liabilities
1,014 579 579 596 1,100 1,180 1,104 1,198 1,223 1,345 1,518
Total Noncurrent Liabilities
10,167 10,222 10,010 9,186 11,440 11,616 12,352 12,084 11,508 12,221 13,180
Long-Term Debt
9,001 8,945 9,158 8,173 7,978 7,917 8,729 8,693 8,268 9,176 10,164
Noncurrent Deferred & Payable Income Tax Liabilities
727 531 486 563 578 810 831 783 726 665 757
Other Noncurrent Operating Liabilities
439 317 365 451 2,885 2,889 2,792 2,608 2,513 2,379 2,259
Redeemable Noncontrolling Interest
864 973 1,011 1,125 1,180 1,330 1,435 1,349 1,499 1,695 1,532
Total Equity & Noncontrolling Interests
5,084 4,850 4,886 3,908 2,319 1,567 936 876 1,244 396 -374
Total Preferred & Common Equity
4,871 4,648 4,690 3,703 2,133 1,384 756 712 1,056 121 -651
Preferred Stock
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Common Equity
4,871 4,648 4,690 3,703 2,133 1,384 756 712 1,056 121 -651
Common Stock
1,119 1,027 1,043 995 749 597 540 607 510 286 0.07
Retained Earnings
4,357 3,710 3,634 2,743 1,432 853 354 174 598 1,535 -328
Treasury Stock
-545 - - - - - - - 0.00 -1,389 -200
Accumulated Other Comprehensive Income / (Loss)
-60 -90 13 -35 -47 -66 -139 -69 -52 -311 -123
Noncontrolling Interest
213 202 196 205 186 183 181 164 188 275 277

Quarterly Balance Sheets for DaVita

This table presents DaVita's assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q1 2026 Q2 2026 Q3 2026
Period end date 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025 9/30/2025 3/31/2026 6/30/2026 9/30/2026
Total Assets
16,894 17,431 17,026 17,504 17,285 17,119 17,493 17,556 17,499 17,709 17,817
Total Current Assets
3,138 3,684 3,467 4,037 3,746 3,636 4,088 4,112 4,063 4,190 4,075
Cash & Equivalents
380 345 416 1,071 795 439 708 706 644 669 496
Restricted Cash
85 86 87 88 85 86 89 89 82 83 84
Short-Term Investments
12 11 21 21 51 73 31 31 22 20 71
Accounts Receivable
2,410 2,991 2,724 2,627 2,530 2,744 2,918 2,855 2,977 3,033 3,074
Inventories, net
143 146 127 129 135 151 146 139 142 152 161
Prepaid Expenses
103 105 83 97 123 130 110 161 160 149 141
Current Deferred & Refundable Income Taxes
6.39 0.00 9.37 4.52 28 14 85 131 36 85 48
Plant, Property, & Equipment, net
3,074 3,026 2,982 2,940 2,941 2,901 2,854 2,853 2,755 2,749 2,731
Total Noncurrent Assets
10,682 10,721 10,576 10,527 10,598 10,582 10,551 10,591 10,682 10,771 11,011
Long-Term Investments
594 540 485 464 370 361 342 300 207 222 443
Goodwill
7,113 7,230 7,201 7,228 7,375 7,416 7,466 7,544 7,582 7,591 7,548
Intangible Assets
203 201 191 198 197 205 212 220 229 229 221
Other Noncurrent Operating Assets
2,773 2,750 2,698 2,637 2,655 2,600 2,531 2,528 2,664 2,729 2,799
Total Liabilities & Shareholders' Equity
16,894 17,431 17,026 17,504 17,285 17,119 17,493 17,556 17,499 17,709 17,817
Total Liabilities
14,150 14,795 14,601 15,284 15,194 15,459 15,940 16,215 16,451 16,630 16,691
Total Current Liabilities
2,642 2,583 2,995 2,944 2,973 2,907 2,934 3,017 2,867 2,855 2,887
Short-Term Debt
123 128 538 296 271 179 182 63 113 117 112
Accounts Payable
515 490 494 488 547 596 594 656 691 716 662
Current Deferred & Payable Income Tax Liabilities
29 83 25 21 10 37 20 26 37 25 23
Current Employee Benefit Liabilities
753 622 645 806 800 677 686 852 708 695 748
Other Current Liabilities
1,223 1,261 1,293 1,332 1,345 1,419 1,451 1,420 1,318 1,303 1,341
Total Noncurrent Liabilities
11,508 12,212 11,606 12,340 12,221 12,552 13,006 13,198 13,584 13,775 13,804
Long-Term Debt
8,268 9,001 8,452 9,260 9,176 9,560 10,079 10,184 10,514 10,664 10,657
Noncurrent Deferred & Payable Income Tax Liabilities
726 720 694 660 665 665 646 742 819 826 862
Other Noncurrent Operating Liabilities
2,513 2,492 2,460 2,420 2,379 2,328 2,281 2,272 2,251 2,285 2,286
Redeemable Noncontrolling Interest
1,499 1,503 1,575 1,633 1,695 1,667 1,661 1,645 1,525 1,561 1,484
Total Equity & Noncontrolling Interests
1,244 1,133 850 587 396 -6.55 -108 -304 -476 -482 -358
Total Preferred & Common Equity
1,056 926 633 387 121 -267 -370 -572 -755 -765 -591
Preferred Stock
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Common Equity
1,056 926 633 387 121 -267 -370 -572 -755 -765 -591
Common Stock
510 428 383 296 286 300 357 402 0.07 0.07 54
Retained Earnings
598 838 1,061 1,275 1,535 1,698 1,897 2,047 -179 81 302
Treasury Stock
0.00 -240 -616 -1,022 -1,389 -2,037 -2,486 -2,905 -489 -788 -917
Accumulated Other Comprehensive Income / (Loss)
-52 -100 -195 -162 -311 -227 -138 -116 -87 -59 -29
Noncontrolling Interest
188 207 217 200 275 261 262 268 279 283 233

Annual Metrics And Ratios for DaVita

This table displays calculated financial ratios and metrics derived from DaVita's official financial filings.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 12/31/2015 12/31/2016 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Growth Metrics
- - - - - - - - - - -
Revenue Growth
-21.02% 7.15% 2.00% 0.38% -0.14% 1.42% 0.59% -0.08% 4.57% 5.56% 6.46%
EBITDA Growth
-25.97% 54.67% -5.42% -18.44% 7.56% 2.36% 6.09% -17.25% 13.29% 17.84% -3.22%
EBIT Growth
-37.01% 77.95% -10.15% -16.09% 8.90% 2.32% 5.40% -26.64% 19.67% 27.60% -3.95%
NOPAT Growth
-33.63% 87.61% -6.47% -17.48% 9.49% 2.55% 11.09% -25.78% 22.40% 31.11% -6.42%
Net Income Growth
-50.49% 141.71% -19.60% -59.90% 206.66% -2.61% 21.82% -35.50% 22.43% 30.70% -13.75%
EPS Growth
-62.46% 243.20% -19.11% -73.49% 472.83% 19.73% 41.05% -34.27% 26.84% 44.61% -8.29%
Operating Cash Flow Growth
35.36% 26.65% -2.99% -7.40% 16.97% -4.50% -2.43% -18.97% 31.60% -1.80% -6.70%
Free Cash Flow Firm Growth
36.34% 542.16% -99.70% 3,488.50% 121.07% -15.87% -3.04% -14.30% 65.93% -9.33% -9.91%
Invested Capital Growth
-1.12% -35.04% 16.28% 4.98% -1.96% 0.61% 2.38% 0.41% -3.75% 1.71% 2.10%
Revenue Q/Q Growth
-25.68% -0.53% 38.48% -0.95% 0.68% 31.47% -18.97% -0.23% 1.92% 1.18% 2.44%
EBITDA Q/Q Growth
-11.31% 13.44% -12.28% 10.54% 4.09% -3.43% 0.50% -5.48% 6.30% 5.62% 0.01%
EBIT Q/Q Growth
-17.18% 17.35% -16.44% 17.76% 5.46% -4.80% -0.05% -9.48% 9.46% 9.02% -0.64%
NOPAT Q/Q Growth
-16.58% 22.50% -7.88% -4.30% 4.61% -4.98% 0.87% -9.36% 9.40% 10.78% -1.94%
Net Income Q/Q Growth
-33.56% 17.49% 22.47% -57.06% 65.66% -6.45% 1.26% -13.58% 12.19% 10.48% -1.66%
EPS Q/Q Growth
-45.18% 23.28% 32.44% -72.46% 93.75% -3.96% 3.37% -14.60% 12.59% 15.50% 1.44%
Operating Cash Flow Q/Q Growth
20.54% 0.47% -7.08% 2.57% 16.34% -9.00% 2.39% -10.63% 7.38% 3.19% -0.36%
Free Cash Flow Firm Q/Q Growth
145.30% 348.60% -98.31% -85.87% 55.30% -24.24% 4.31% -6.44% 15.21% 5.19% 6.43%
Invested Capital Q/Q Growth
-1.17% -35.15% -26.95% 3.43% -1.20% 2.03% 1.62% 1.22% 0.14% 1.03% -0.10%
Profitability Metrics
- - - - - - - - - - -
Gross Margin
29.98% 29.30% 28.49% 28.14% 30.50% 30.84% 31.38% 29.29% 31.47% 32.91% 32.25%
EBITDA Margin
17.15% 24.76% 22.95% 18.65% 20.09% 20.27% 21.38% 17.71% 19.18% 21.42% 19.47%
Operating Margin
10.94% 18.22% 15.95% 13.38% 14.43% 14.67% 15.47% 11.53% 13.20% 16.31% 14.98%
EBIT Margin
11.01% 18.29% 16.11% 13.47% 14.69% 14.82% 15.52% 11.40% 13.04% 15.77% 14.23%
Profit (Net Income) Margin
4.11% 9.27% 7.31% 2.92% 8.97% 8.61% 10.43% 6.73% 7.88% 9.76% 7.91%
Tax Burden Percent
62.09% 63.65% 59.33% 31.76% 85.43% 75.45% 79.80% 80.89% 81.30% 81.73% 80.09%
Interest Burden Percent
60.13% 79.67% 76.47% 68.26% 71.47% 77.03% 84.19% 73.02% 74.33% 75.74% 69.39%
Effective Tax Rate
30.14% 26.60% 23.14% 24.65% 23.39% 23.81% 20.20% 20.50% 18.70% 18.27% 21.76%
Return on Invested Capital (ROIC)
6.07% 13.89% 15.25% 11.42% 12.33% 12.73% 13.94% 10.20% 12.70% 16.83% 15.46%
ROIC Less NNEP Spread (ROIC-NNEP)
0.84% 4.45% -1.93% -6.33% 8.33% 8.46% 11.03% 6.72% 8.25% 10.91% 9.49%
Return on Net Nonoperating Assets (RNNOA)
0.97% 3.66% -1.08% -5.33% 11.61% 18.37% 32.07% 23.81% 25.83% 34.91% 50.93%
Return on Equity (ROE)
7.04% 17.55% 14.17% 6.09% 23.94% 31.10% 46.01% 34.02% 38.52% 51.74% 66.39%
Cash Return on Invested Capital (CROIC)
7.20% 56.37% 0.20% 6.56% 14.31% 12.12% 11.58% 9.79% 16.52% 15.14% 13.38%
Operating Return on Assets (OROA)
6.34% 10.93% 9.70% 8.07% 9.19% 9.98% 10.58% 7.77% 9.36% 11.82% 11.17%
Return on Assets (ROA)
2.37% 5.54% 4.40% 1.75% 5.61% 5.80% 7.11% 4.59% 5.66% 7.32% 6.21%
Return on Common Equity (ROCE)
5.83% 14.19% 11.29% 4.68% 16.38% 17.10% 18.68% 10.86% 13.71% 12.60% -10.83%
Return on Equity Simple (ROE_SIMPLE)
8.78% 22.23% 17.71% 8.99% 47.87% 71.89% 160.39% 109.73% 90.61% 1,032.63% 0.00%
Net Operating Profit after Tax (NOPAT)
794 1,490 1,393 1,150 1,259 1,291 1,434 1,065 1,303 1,708 1,599
NOPAT Margin
7.64% 13.37% 12.26% 10.08% 11.05% 11.18% 12.34% 9.17% 10.73% 13.33% 11.72%
Net Nonoperating Expense Percent (NNEP)
5.23% 9.44% 17.19% 17.75% 4.00% 4.27% 2.91% 3.48% 4.45% 5.92% 5.97%
Return On Investment Capital (ROIC_SIMPLE)
- - - - - - - 10.86% 13.52% 17.36% 16.15%
Cost of Revenue to Revenue
70.02% 70.70% 71.51% 71.86% 69.50% 69.16% 68.62% 70.71% 68.53% 67.09% 67.75%
SG&A Expenses to Revenue
9.92% 9.63% 9.36% 9.96% 9.69% 10.80% 10.29% 11.67% 12.14% 12.00% 12.27%
R&D to Revenue
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Operating Expenses to Revenue
19.05% 11.08% 12.66% 14.89% 16.07% 16.17% 15.91% 17.75% 18.27% 16.59% 17.27%
Earnings before Interest and Taxes (EBIT)
1,145 2,037 1,830 1,536 1,673 1,711 1,804 1,323 1,584 2,021 1,941
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)
1,783 2,757 2,608 2,127 2,288 2,342 2,484 2,056 2,329 2,745 2,656
Valuation Ratios
- - - - - - - - - - -
Price to Book Value (P/BV)
3.02 2.73 2.82 2.31 4.56 9.50 15.34 9.44 9.06 101.25 0.00
Price to Tangible Book Value (P/TBV)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Price to Revenue (P/Rev)
1.42 1.14 1.17 0.75 0.85 1.14 1.00 0.58 0.79 0.96 0.59
Price to Earnings (P/E)
54.53 14.40 19.96 53.59 12.00 17.00 11.85 12.01 13.83 13.10 10.74
Dividend Yield
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Earnings Yield
1.83% 6.94% 5.01% 1.87% 8.33% 5.88% 8.44% 8.33% 7.23% 7.64% 9.31%
Enterprise Value to Invested Capital (EV/IC)
1.76 2.54 2.34 1.87 1.75 2.16 2.04 1.58 1.85 2.19 1.83
Enterprise Value to Revenue (EV/Rev)
2.20 1.93 2.02 1.69 1.55 1.90 1.83 1.42 1.53 1.75 1.40
Enterprise Value to EBITDA (EV/EBITDA)
12.81 7.78 8.80 9.07 7.74 9.37 8.55 8.01 7.97 8.15 7.20
Enterprise Value to EBIT (EV/EBIT)
19.95 10.53 12.54 12.56 10.59 12.82 11.78 12.45 11.73 11.07 9.85
Enterprise Value to NOPAT (EV/NOPAT)
28.76 14.40 16.47 16.78 14.07 16.99 14.82 15.47 14.25 13.10 11.96
Enterprise Value to Operating Cash Flow (EV/OCF)
14.67 10.88 12.00 10.89 8.54 11.08 11.01 10.53 9.02 11.07 10.14
Enterprise Value to Free Cash Flow (EV/FCFF)
24.26 3.55 1,246.37 29.20 12.12 17.85 17.83 16.13 10.96 14.56 13.81
Leverage & Solvency
- - - - - - - - - - -
Debt to Equity
1.54 1.56 1.58 2.01 2.32 2.79 3.76 4.01 3.06 4.52 8.87
Long-Term Debt to Equity
1.51 1.54 1.55 1.62 2.28 2.73 3.68 3.91 3.01 4.39 8.77
Financial Leverage
1.15 0.82 0.56 0.84 1.39 2.17 2.91 3.54 3.13 3.20 5.37
Leverage Ratio
2.98 3.17 3.22 3.48 4.27 5.36 6.48 7.41 6.81 7.07 10.70
Compound Leverage Factor
1.79 2.52 2.46 2.38 3.05 4.13 5.45 5.41 5.06 5.35 7.42
Debt to Total Capital
60.55% 60.99% 61.29% 66.75% 69.85% 73.62% 78.98% 80.04% 75.36% 81.87% 89.87%
Short-Term Debt to Total Capital
0.86% 1.07% 1.17% 12.75% 1.13% 1.53% 1.59% 2.08% 1.11% 2.35% 0.96%
Long-Term Debt to Total Capital
59.70% 59.92% 60.12% 54.00% 68.73% 72.09% 77.39% 77.97% 74.26% 79.53% 88.91%
Preferred Equity to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital
7.15% 7.87% 7.93% 8.78% 11.77% 13.78% 14.32% 13.57% 15.15% 17.08% 15.83%
Common Equity to Total Capital
32.30% 31.14% 30.79% 24.47% 18.38% 12.60% 6.70% 6.39% 9.48% 1.05% -5.70%
Debt to EBITDA
5.12 3.30 3.58 4.75 3.54 3.45 3.59 4.34 3.60 3.44 3.87
Net Debt to EBITDA
3.96 2.76 3.26 4.43 2.89 3.11 3.24 4.00 3.14 2.97 3.50
Long-Term Debt to EBITDA
5.05 3.24 3.51 3.84 3.49 3.38 3.51 4.23 3.55 3.34 3.83
Debt to NOPAT
11.50 6.11 6.70 8.79 6.44 6.26 6.21 8.38 6.44 5.53 6.43
Net Debt to NOPAT
8.89 5.10 6.10 8.20 5.25 5.63 5.61 7.73 5.62 4.77 5.81
Long-Term Debt to NOPAT
11.34 6.00 6.57 7.11 6.34 6.13 6.09 8.17 6.35 5.37 6.36
Altman Z-Score
1.93 1.90 2.15 1.65 1.61 1.69 1.58 1.27 1.52 1.79 1.48
Noncontrolling Interest Sharing Ratio
17.28% 19.13% 20.33% 23.21% 31.59% 45.02% 59.39% 68.06% 64.40% 75.65% 116.31%
Liquidity Ratios
- - - - - - - - - - -
Current Ratio
1.88 1.47 2.86 1.72 1.56 1.27 1.32 1.20 1.19 1.26 1.29
Quick Ratio
1.70 1.02 0.87 0.54 1.43 1.10 1.20 1.09 1.06 1.14 1.15
Cash Flow Metrics
- - - - - - - - - - -
Free Cash Flow to Firm (FCFF)
942 6,047 18 661 1,461 1,229 1,192 1,021 1,695 1,537 1,384
Operating Cash Flow to CapEx
219.94% 237.86% 211.34% 179.47% 270.35% 293.39% 301.01% 259.28% 362.52% 364.04% 327.59%
Free Cash Flow to Firm to Interest Expense
2.31 14.60 0.04 1.36 3.06 3.13 4.18 2.86 4.25 3.13 2.33
Operating Cash Flow to Interest Expense
3.81 4.76 4.44 3.63 4.34 5.03 6.77 4.38 5.17 4.12 3.18
Operating Cash Flow Less CapEx to Interest Expense
2.08 2.76 2.34 1.61 2.74 3.32 4.52 2.69 3.74 2.99 2.21
Efficiency Ratios
- - - - - - - - - - -
Asset Turnover
0.58 0.60 0.60 0.60 0.63 0.67 0.68 0.68 0.72 0.75 0.78
Accounts Receivable Turnover
5.09 5.64 5.82 5.13 4.94 4.96 4.89 4.71 4.90 5.19 5.02
Inventory Turnover
45.25 45.52 47.49 56.68 77.09 76.24 72.79 75.82 65.97 61.93 62.63
Fixed Asset Turnover
3.95 3.94 3.78 3.49 3.32 3.30 3.32 3.45 3.84 4.26 4.74
Accounts Payable Turnover
15.17 16.23 16.83 16.86 18.25 19.06 19.07 18.62 16.73 16.20 14.87
Days Sales Outstanding (DSO)
71.75 64.75 62.74 71.09 73.93 73.53 74.67 77.51 74.50 70.34 72.76
Days Inventory Outstanding (DIO)
8.07 8.02 7.69 6.44 4.73 4.79 5.01 4.81 5.53 5.89 5.83
Days Payable Outstanding (DPO)
24.06 22.49 21.69 21.65 19.99 19.15 19.14 19.60 21.81 22.53 24.55
Cash Conversion Cycle (CCC)
55.76 50.28 48.74 55.87 58.67 59.17 60.54 62.72 58.22 53.70 54.04
Capital & Investment Metrics
- - - - - - - - - - -
Invested Capital
13,004 8,447 9,822 10,311 10,109 10,171 10,413 10,457 10,065 10,237 10,451
Invested Capital Turnover
0.79 1.04 1.24 1.13 1.12 1.14 1.13 1.11 1.18 1.26 1.32
Increase / (Decrease) in Invested Capital
-147 -4,557 1,375 489 -202 62 242 43 -392 172 214
Enterprise Value (EV)
22,842 21,449 22,952 19,296 17,707 21,936 21,250 16,472 18,573 22,379 19,123
Market Capitalization
14,709 12,673 13,243 8,542 9,731 13,149 11,592 6,728 9,565 12,263 8,021
Book Value per Share
$23.08 $23.55 $25.59 $22.31 $16.45 $12.35 $7.41 $7.91 $11.57 $1.48 ($9.22)
Tangible Book Value per Share
($28.96) ($7.30) ($11.10) ($19.62) ($36.93) ($50.91) ($63.48) ($72.66) ($68.56) ($90.87) ($119.24)
Total Capital
15,079 14,928 15,234 15,135 11,608 10,983 11,279 11,149 11,135 11,538 11,432
Total Debt
9,130 9,105 9,336 10,102 8,108 8,086 8,908 8,924 8,392 9,447 10,273
Total Long-Term Debt
9,001 8,945 9,158 8,173 7,978 7,917 8,729 8,693 8,268 9,176 10,164
Net Debt
7,056 7,601 8,501 9,424 6,609 7,274 8,043 8,232 7,322 8,146 9,293
Capital Expenditures (CapEx)
708 829 905 987 767 675 641 603 568 555 576
Debt-free, Cash-free Net Working Capital (DFCFNWC)
326 462 5,330 5,044 228 319 371 350 143 113 244
Debt-free Net Working Capital (DFNWC)
2,233 1,444 5,881 5,462 1,449 841 948 767 619 1,044 1,026
Net Working Capital (NWC)
2,104 1,284 5,703 3,533 1,318 673 769 536 496 773 916
Net Nonoperating Expense (NNE)
367 457 563 817 238 296 223 283 346 458 520
Net Nonoperating Obligations (NNO)
7,056 2,624 3,925 5,278 6,609 7,274 8,043 8,232 7,322 8,146 9,293
Total Depreciation and Amortization (D&A)
638 720 777 591 615 630 681 733 745 724 715
Debt-free, Cash-free Net Working Capital to Revenue
3.14% 4.15% 46.91% 44.23% 2.01% 2.76% 3.19% 3.02% 1.18% 0.88% 1.78%
Debt-free Net Working Capital to Revenue
21.48% 12.96% 51.76% 47.90% 12.72% 7.28% 8.16% 6.61% 5.10% 8.14% 7.52%
Net Working Capital to Revenue
20.24% 11.53% 50.20% 30.98% 11.57% 5.82% 6.62% 4.61% 4.08% 6.03% 6.72%
Earnings Adjustments
- - - - - - - - - - -
Adjusted Basic Earnings per Share
$1.27 $4.36 $3.52 $159,394,000.93 $5.29 $6.46 $9.30 $6.03 $7.62 $11.02 $10.06
Adjusted Weighted Average Basic Shares Outstanding
211.87M 201.64M 188.63M 170.79M 153.18M 119.80M 105.23M 92.99M 90.79M 84.99M 74.23M
Adjusted Diluted Earnings per Share
$1.25 $4.29 $3.47 $0.92 $5.27 $6.31 $8.90 $5.85 $7.42 $10.73 $9.84
Adjusted Weighted Average Diluted Shares Outstanding
216.25M 204.90M 191.35M 172.36M 153.81M 122.62M 109.95M 95.83M 93.18M 87.27M 75.89M
Adjusted Basic & Diluted Earnings per Share
$0.00 $0.00 $0.00 $0.00 $5.29 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding
206.10M 194.60M 182M 166.40M 125.60M 109.40M 96.30M 90.40M 87.70M 80M 66.80M
Normalized Net Operating Profit after Tax (NOPAT)
1,133 1,509 1,245 1,123 1,345 1,271 1,413 1,043 1,302 1,598 1,599
Normalized NOPAT Margin
10.90% 13.55% 10.96% 9.85% 11.81% 11.00% 12.16% 8.99% 10.72% 12.47% 11.72%
Pre Tax Income Margin
6.62% 14.57% 12.32% 9.19% 10.50% 11.41% 13.07% 8.32% 9.70% 11.94% 9.87%
Debt Service Ratios
- - - - - - - - - - -
EBIT to Interest Expense
2.80 4.92 4.25 3.15 3.51 4.35 6.32 3.71 3.97 4.12 3.27
NOPAT to Interest Expense
1.94 3.60 3.24 2.36 2.64 3.28 5.03 2.98 3.27 3.48 2.69
EBIT Less CapEx to Interest Expense
1.07 2.92 2.15 1.13 1.90 2.64 4.07 2.02 2.55 2.99 2.30
NOPAT Less CapEx to Interest Expense
0.21 1.60 1.13 0.33 1.03 1.57 2.78 1.29 1.84 2.35 1.72
Payout Ratios
- - - - - - - - - - -
Dividend Payout Ratio
56.39% 20.71% 26.11% 67.42% 29.49% 26.23% 21.80% 36.94% 30.67% 31.26% 32.47%
Augmented Payout Ratio
185.06% 126.97% 122.78% 416.18% 262.90% 172.86% 148.77% 139.57% 59.11% 142.07% 153.76%

Quarterly Metrics And Ratios for DaVita

This table displays calculated financial ratios and metrics derived from DaVita's official financial filings.

Metric Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026 Q2 2026 Q3 2026
Period end date 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025 9/30/2025 12/31/2025 3/31/2026 6/30/2026 9/30/2026
DEI Shares Outstanding
- - - - - - - - 66,800,000.00 64,200,000.00 63,800,000.00
DEI Adjusted Shares Outstanding
- - - - - - - - 66,800,000.00 64,200,000.00 63,800,000.00
DEI Earnings Per Adjusted Shares Outstanding
- - - - - - - - 2.96 4.13 3.49
Growth Metrics
- - - - - - - - - - -
Revenue Growth
6.89% 6.21% 4.56% 4.73% 4.98% 6.05% 4.80% 9.87% 5.96% 5.17% 4.62%
EBITDA Growth
33.40% 10.88% 6.08% 25.15% -9.18% 5.36% -8.95% 0.03% 11.10% 9.48% 4.97%
EBIT Growth
49.40% 17.77% 8.78% 43.40% -10.57% 7.53% -10.34% -2.25% 15.42% 14.04% 9.52%
NOPAT Growth
60.68% 20.81% 4.43% 53.45% -10.60% -1.82% -7.11% -6.00% 9.11% 13.86% -4.71%
Net Income Growth
79.28% 21.66% -4.40% 51.47% -24.11% -8.18% -18.77% -5.22% 18.44% 24.71% 12.13%
EPS Growth
112.00% 30.89% -4.58% 87.80% -24.53% 3.20% -18.40% 4.55% 43.50% 55.81% 66.67%
Operating Cash Flow Growth
-129.15% 77.48% 22.57% 12.87% 233.50% -59.41% 3.84% -1.26% 78.23% 51.15% -38.35%
Free Cash Flow Firm Growth
-111.30% -65.63% -50.09% -56.55% 1,405.92% -37.45% -81.36% -23.33% -84.40% 45.12% -45.71%
Invested Capital Growth
4.37% 1.46% 0.81% 1.71% -3.18% 2.30% 3.25% 2.10% 2.68% 2.09% 3.25%
Revenue Q/Q Growth
-2.39% 3.78% 2.41% 0.95% -2.16% 4.84% 1.20% 5.83% -5.64% 4.06% 0.68%
EBITDA Q/Q Growth
13.39% -0.56% 7.72% 3.04% -17.72% 15.36% -6.92% 13.20% -8.61% 13.69% -10.75%
EBIT Q/Q Growth
22.31% 1.64% 8.18% 6.63% -23.72% 22.21% -9.80% 16.26% -9.94% 20.75% -13.38%
NOPAT Q/Q Growth
28.04% 2.63% 3.66% 12.66% -25.41% 12.71% -1.93% 14.01% -13.42% 17.62% -17.93%
Net Income Q/Q Growth
32.70% -2.04% -1.33% 18.08% -33.51% 18.52% -12.71% 37.79% -16.92% 24.79% -21.51%
EPS Q/Q Growth
61.59% -5.66% 0.00% 23.20% -35.06% 29.00% -20.93% 57.84% -10.87% 40.07% -15.42%
Operating Cash Flow Q/Q Growth
-127.79% 692.46% 1.45% -32.43% -67.13% 80.12% 159.54% -35.74% -40.67% 52.75% 5.87%
Free Cash Flow Firm Q/Q Growth
-107.62% 583.16% 32.29% -10.76% 128.94% -76.86% -60.57% 267.07% -53.43% 115.31% -85.25%
Invested Capital Q/Q Growth
7.13% -3.50% -2.62% 1.03% 1.98% 1.96% -1.71% -0.10% 2.56% 1.38% -0.59%
Profitability Metrics
- - - - - - - - - - -
Gross Margin
32.29% 32.77% 34.06% 32.46% 30.52% 33.08% 31.80% 33.43% 31.42% 32.70% 31.50%
EBITDA Margin
21.44% 20.54% 21.61% 22.05% 18.55% 20.41% 18.77% 20.08% 19.45% 21.25% 18.83%
Operating Margin
15.76% 15.89% 16.39% 17.16% 13.62% 15.91% 14.79% 15.50% 14.11% 16.29% 13.95%
EBIT Margin
15.35% 15.03% 15.88% 16.77% 13.07% 15.24% 13.58% 14.92% 14.24% 16.52% 14.22%
Profit (Net Income) Margin
9.97% 9.41% 9.06% 10.60% 7.20% 8.14% 7.02% 9.15% 8.05% 9.66% 7.53%
Tax Burden Percent
82.30% 80.70% 79.20% 84.41% 81.10% 74.60% 77.80% 86.49% 80.60% 78.90% 75.10%
Interest Burden Percent
78.90% 77.56% 72.08% 74.89% 67.95% 71.64% 66.48% 70.88% 70.16% 74.07% 70.51%
Effective Tax Rate
17.70% 19.30% 20.80% 15.59% 18.90% 25.40% 22.20% 20.05% 19.40% 21.10% 24.90%
Return on Invested Capital (ROIC)
15.16% 15.55% 16.29% 18.29% 13.50% 14.85% 14.88% 16.35% 14.87% 16.74% 13.96%
ROIC Less NNEP Spread (ROIC-NNEP)
14.01% 14.15% 14.60% 16.63% 12.03% 13.37% 13.08% 15.00% 13.64% 15.54% 12.84%
Return on Net Nonoperating Assets (RNNOA)
44.50% 43.69% 43.83% 53.21% 47.41% 57.38% 62.58% 80.47% 92.95% 111.44% 97.86%
Return on Equity (ROE)
59.66% 59.24% 60.12% 71.50% 60.91% 72.23% 77.46% 96.82% 107.82% 128.18% 111.82%
Cash Return on Invested Capital (CROIC)
9.49% 13.30% 14.48% 15.14% 18.94% 13.49% 12.63% 13.38% 12.79% 13.63% 12.49%
Operating Return on Assets (OROA)
11.09% 11.08% 11.68% 12.57% 9.81% 11.62% 10.32% 11.71% 11.38% 13.15% 11.39%
Return on Assets (ROA)
7.20% 6.93% 6.67% 7.95% 5.41% 6.21% 5.34% 7.18% 6.44% 7.69% 6.03%
Return on Common Equity (ROCE)
20.67% 19.34% 18.90% 17.41% 9.34% 4.78% -4.03% -15.79% -40.71% -55.25% -52.72%
Return on Equity Simple (ROE_SIMPLE)
117.96% 181.02% 292.74% 0.00% -440.65% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Net Operating Profit after Tax (NOPAT)
398 409 424 477 356 401 393 449 388 457 375
NOPAT Margin
12.97% 12.82% 12.98% 14.49% 11.04% 11.87% 11.50% 12.39% 11.37% 12.85% 10.48%
Net Nonoperating Expense Percent (NNEP)
1.15% 1.40% 1.69% 1.66% 1.46% 1.48% 1.80% 1.35% 1.23% 1.20% 1.12%
Return On Investment Capital (ROIC_SIMPLE)
- - - 4.85% 3.66% 3.95% 3.96% 4.53% 3.83% 4.44% 3.60%
Cost of Revenue to Revenue
67.71% 67.23% 65.94% 67.54% 69.48% 66.92% 68.20% 66.57% 68.58% 67.30% 68.50%
SG&A Expenses to Revenue
11.81% 11.54% 12.06% 12.58% 11.61% 12.21% 12.12% 13.05% 12.35% 11.91% 11.42%
R&D to Revenue
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Operating Expenses to Revenue
16.54% 16.88% 17.67% 15.30% 16.90% 17.17% 17.01% 17.93% 17.31% 16.41% 17.55%
Earnings before Interest and Taxes (EBIT)
471 479 518 552 421 515 465 540 486 587 509
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)
658 655 705 727 598 690 642 727 664 755 674
Valuation Ratios
- - - - - - - - - - -
Price to Book Value (P/BV)
13.61 19.20 35.57 101.25 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Price to Tangible Book Value (P/TBV)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Price to Revenue (P/Rev)
1.02 0.97 1.09 0.96 0.94 0.82 0.71 0.59 0.74 1.02 0.79
Price to Earnings (P/E)
15.45 14.14 16.62 13.10 14.24 12.86 12.31 10.74 13.14 16.85 12.13
Dividend Yield
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Earnings Yield
6.47% 7.07% 6.02% 7.64% 7.02% 7.78% 8.13% 9.31% 7.61% 5.93% 8.24%
Enterprise Value to Invested Capital (EV/IC)
2.08 2.11 2.32 2.19 2.20 2.05 1.96 1.83 2.03 2.38 2.09
Enterprise Value to Revenue (EV/Rev)
1.82 1.75 1.86 1.75 1.77 1.65 1.54 1.40 1.57 1.85 1.59
Enterprise Value to EBITDA (EV/EBITDA)
9.01 8.57 9.04 8.15 8.55 8.01 7.73 7.20 7.99 9.30 8.00
Enterprise Value to EBIT (EV/EBIT)
12.91 12.10 12.68 11.07 11.64 10.85 10.51 9.85 10.84 12.47 10.63
Enterprise Value to NOPAT (EV/NOPAT)
15.46 14.39 15.24 13.10 13.77 13.12 12.59 11.96 13.32 15.35 13.52
Enterprise Value to Operating Cash Flow (EV/OCF)
15.37 12.11 11.99 11.07 9.82 11.69 10.85 10.14 10.72 11.82 12.06
Enterprise Value to Free Cash Flow (EV/FCFF)
22.43 15.96 16.09 14.56 11.42 15.33 15.79 13.81 16.07 17.68 16.98
Leverage & Solvency
- - - - - - - - - - -
Debt to Equity
3.46 3.71 4.31 4.52 5.87 6.61 7.64 8.87 10.14 9.99 9.57
Long-Term Debt to Equity
3.41 3.49 4.17 4.39 5.76 6.49 7.60 8.77 10.03 9.88 9.47
Financial Leverage
3.18 3.09 3.00 3.20 3.94 4.29 4.78 5.37 6.81 7.17 7.62
Leverage Ratio
6.76 6.72 6.83 7.07 8.04 8.68 9.85 10.70 12.78 13.37 14.34
Compound Leverage Factor
5.33 5.21 4.92 5.29 5.46 6.22 6.55 7.58 8.97 9.90 10.11
Debt to Total Capital
77.59% 78.76% 81.15% 81.87% 85.44% 86.85% 88.43% 89.87% 91.02% 90.90% 90.54%
Short-Term Debt to Total Capital
1.08% 4.71% 2.52% 2.35% 1.57% 1.54% 0.54% 0.96% 0.97% 0.99% 0.95%
Long-Term Debt to Total Capital
76.51% 74.04% 78.64% 79.53% 83.87% 85.31% 87.89% 88.91% 90.06% 89.91% 89.59%
Preferred Equity to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital
14.54% 15.70% 15.56% 17.08% 16.91% 16.27% 16.51% 15.83% 15.45% 15.55% 14.43%
Common Equity to Total Capital
7.87% 5.54% 3.28% 1.05% -2.34% -3.13% -4.94% -5.70% -6.47% -6.45% -4.97%
Debt to EBITDA
3.66 3.51 3.68 3.44 3.63 3.77 3.86 3.87 3.90 3.87 3.82
Net Debt to EBITDA
3.27 3.12 3.05 2.97 3.27 3.34 3.43 3.50 3.55 3.51 3.43
Long-Term Debt to EBITDA
3.61 3.30 3.56 3.34 3.56 3.71 3.83 3.83 3.86 3.82 3.78
Debt to NOPAT
6.28 5.90 6.20 5.53 5.84 6.18 6.28 6.43 6.51 6.39 6.46
Net Debt to NOPAT
5.61 5.24 5.13 4.77 5.27 5.48 5.59 5.81 5.92 5.80 5.80
Long-Term Debt to NOPAT
6.19 5.55 6.00 5.37 5.74 6.07 6.25 6.36 6.44 6.32 6.39
Altman Z-Score
1.45 1.45 1.54 1.51 1.50 1.49 1.44 1.21 1.32 1.51 1.39
Noncontrolling Interest Sharing Ratio
65.35% 67.35% 68.56% 75.65% 84.66% 93.38% 105.20% 116.31% 137.76% 143.11% 147.15%
Liquidity Ratios
- - - - - - - - - - -
Current Ratio
1.43 1.16 1.37 1.26 1.25 1.39 1.36 1.29 1.42 1.47 1.41
Quick Ratio
1.30 1.06 1.26 1.14 1.12 1.25 1.19 1.15 1.27 1.30 1.26
Cash Flow Metrics
- - - - - - - - - - -
Free Cash Flow to Firm (FCFF)
-54 259 342 305 699 162 64 234 109 235 35
Operating Cash Flow to CapEx
-111.42% 640.49% 582.83% 320.89% 125.65% 267.76% 506.69% 371.81% 314.48% 288.58% 325.31%
Free Cash Flow to Firm to Interest Expense
-0.54 2.41 2.37 2.20 5.18 1.11 0.41 1.49 0.75 1.54 0.23
Operating Cash Flow to Interest Expense
-1.36 7.43 5.60 3.95 1.33 2.22 5.40 3.44 2.21 3.22 3.46
Operating Cash Flow Less CapEx to Interest Expense
-2.57 6.27 4.64 2.72 0.27 1.39 4.34 2.51 1.51 2.10 2.40
Efficiency Ratios
- - - - - - - - - - -
Asset Turnover
0.72 0.74 0.74 0.75 0.75 0.76 0.76 0.78 0.80 0.80 0.80
Accounts Receivable Turnover
4.59 4.92 5.06 5.19 4.52 4.67 4.86 5.02 4.84 4.71 4.78
Inventory Turnover
66.04 71.09 71.34 61.93 59.12 65.03 67.58 62.63 63.98 63.64 63.85
Fixed Asset Turnover
3.95 4.08 4.20 4.26 4.38 4.51 4.60 4.74 4.89 5.00 5.07
Accounts Payable Turnover
17.79 18.29 18.43 16.20 16.13 16.32 15.84 14.87 14.52 14.47 14.56
Days Sales Outstanding (DSO)
79.48 74.15 72.11 70.34 80.71 78.24 75.12 72.76 75.47 77.52 76.38
Days Inventory Outstanding (DIO)
5.53 5.13 5.12 5.89 6.17 5.61 5.40 5.83 5.70 5.74 5.72
Days Payable Outstanding (DPO)
20.52 19.96 19.80 22.53 22.63 22.36 23.04 24.55 25.14 25.23 25.07
Cash Conversion Cycle (CCC)
64.49 59.32 57.42 53.70 64.25 61.49 57.48 54.04 56.03 58.03 57.03
Capital & Investment Metrics
- - - - - - - - - - -
Invested Capital
10,783 10,405 10,132 10,237 10,439 10,644 10,462 10,451 10,719 10,867 10,802
Invested Capital Turnover
1.17 1.21 1.26 1.26 1.22 1.25 1.29 1.32 1.31 1.30 1.33
Increase / (Decrease) in Invested Capital
452 150 81 172 -343 239 330 214 279 222 340
Enterprise Value (EV)
22,461 21,925 23,499 22,379 22,944 21,769 20,534 19,123 21,741 25,915 22,553
Market Capitalization
12,604 12,153 13,754 12,263 12,238 10,755 9,500 8,021 10,266 14,283 11,160
Book Value per Share
$10.55 $7.22 $4.61 $1.48 ($3.34) ($4.90) ($8.00) ($9.22) ($11.31) ($11.92) ($9.26)
Tangible Book Value per Share
($74.11) ($77.08) ($83.89) ($90.87) ($98.60) ($106.58) ($116.58) ($119.24) ($128.25) ($133.72) ($131.04)
Total Capital
11,764 11,414 11,776 11,538 11,398 11,814 11,588 11,432 11,674 11,860 11,895
Total Debt
9,128 8,990 9,557 9,447 9,738 10,261 10,247 10,273 10,626 10,781 10,769
Total Long-Term Debt
9,001 8,452 9,260 9,176 9,560 10,079 10,184 10,164 10,514 10,664 10,657
Net Debt
8,147 7,980 7,913 8,146 8,779 9,091 9,121 9,293 9,671 9,787 9,676
Capital Expenditures (CapEx)
121 125 139 171 143 121 166 145 102 170 159
Debt-free, Cash-free Net Working Capital (DFCFNWC)
787 486 210 113 310 509 332 244 559 680 651
Debt-free Net Working Capital (DFNWC)
1,228 1,010 1,389 1,044 908 1,337 1,158 1,026 1,308 1,451 1,301
Net Working Capital (NWC)
1,101 472 1,093 773 729 1,154 1,095 916 1,195 1,334 1,188
Net Nonoperating Expense (NNE)
92 109 128 128 124 126 153 118 113 114 106
Net Nonoperating Obligations (NNO)
8,147 7,980 7,913 8,146 8,779 9,091 9,121 9,293 9,671 9,787 9,676
Total Depreciation and Amortization (D&A)
187 176 187 174 176 175 177 187 178 168 165
Debt-free, Cash-free Net Working Capital to Revenue
6.38% 3.88% 1.66% 0.88% 2.39% 3.87% 2.49% 1.78% 4.04% 4.85% 4.59%
Debt-free Net Working Capital to Revenue
9.96% 8.07% 10.97% 8.14% 7.00% 10.16% 8.69% 7.52% 9.45% 10.36% 9.18%
Net Working Capital to Revenue
8.92% 3.77% 8.63% 6.03% 5.62% 8.77% 8.22% 6.72% 8.64% 9.52% 8.39%
Earnings Adjustments
- - - - - - - - - - -
Adjusted Basic Earnings per Share
$2.73 $2.56 $2.56 $3.17 $2.05 $2.62 $2.09 $3.30 $2.93 $4.10 $3.49
Adjusted Weighted Average Basic Shares Outstanding
87.78M 86.90M 83.72M 84.99M 79.37M 75.94M 72.08M 74.23M 67.39M 64.78M 63.84M
Adjusted Diluted Earnings per Share
$2.65 $2.50 $2.50 $3.08 $2.00 $2.58 $2.04 $3.22 $2.87 $4.02 $3.40
Adjusted Weighted Average Diluted Shares Outstanding
90.55M 88.95M 85.80M 87.27M 81.28M 77.36M 73.77M 75.89M 68.88M 66.09M 65.50M
Adjusted Basic & Diluted Earnings per Share
$0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding
87.70M 83.90M 82M 80M 75.50M 71.50M 70.60M 66.80M 64.20M 63.80M 62.90M
Normalized Net Operating Profit after Tax (NOPAT)
369 409 424 392 356 401 393 449 388 457 415
Normalized NOPAT Margin
12.03% 12.82% 12.98% 11.91% 11.04% 11.87% 11.50% 12.39% 11.37% 12.85% 11.61%
Pre Tax Income Margin
12.11% 11.66% 11.44% 12.56% 8.88% 10.92% 9.03% 10.57% 9.99% 12.24% 10.03%
Debt Service Ratios
- - - - - - - - - - -
EBIT to Interest Expense
4.74 4.46 3.58 3.98 3.12 3.53 2.98 3.43 3.35 3.86 3.39
NOPAT to Interest Expense
4.01 3.80 2.93 3.44 2.64 2.75 2.53 2.85 2.68 3.00 2.50
EBIT Less CapEx to Interest Expense
3.52 3.30 2.62 2.75 2.06 2.70 1.92 2.51 2.65 2.74 2.33
NOPAT Less CapEx to Interest Expense
2.79 2.64 1.97 2.21 1.58 1.92 1.46 1.93 1.97 1.88 1.44
Payout Ratios
- - - - - - - - - - -
Dividend Payout Ratio
29.41% 27.03% 31.11% 31.26% 34.57% 34.67% 33.74% 32.47% 31.69% 30.45% 34.10%
Augmented Payout Ratio
77.31% 104.26% 145.31% 142.07% 174.34% 170.65% 161.30% 153.76% 120.37% 105.47% 93.62%

Financials Breakdown Chart

Key Financial Trends

DaVita’s financial performance has improved meaningfully since 2023, although leverage and negative common equity remain important risks. Quarterly revenue increased from $3.00 billion in Q2 2023 to $3.55 billion in Q2 2026, an approximately 18% gain. Over the same period, net income attributable to common shareholders rose from $178.7 million to $265.4 million, while diluted earnings per share more than doubled from $1.91 to $4.02.

  • Revenue growth remains consistent. Q2 2026 revenue rose 4.1% sequentially from Q1 2026 and 5.2% from Q2 2025. Revenue has generally trended upward from roughly $2.87 billion in Q1 2023 to $3.55 billion in the latest quarter.
  • Operating profitability has improved. Q2 2026 operating income was $579.0 million, compared with $405.3 million in Q2 2023. The operating margin expanded to approximately 16.3% from 13.5%, indicating that operating earnings have grown faster than revenue.
  • Common-shareholder earnings have grown substantially. Net income attributable to common shareholders increased approximately 49% from Q2 2023 to Q2 2026. The latest quarter also improved from $197.5 million in Q1 2026.
  • Share repurchases have amplified per-share results. Diluted weighted-average shares declined from 93.4 million in Q2 2023 to 66.1 million in Q2 2026. This reduction helped diluted EPS rise from $1.91 to $4.02, despite higher interest expense and significant debt levels.
  • DaVita continues to generate positive operating cash flow. Q2 2026 operating cash flow was $490.1 million, well above the $180.0 million reported in Q1 2025 and sufficient to cover $169.8 million of capital expenditures. Approximate quarterly operating cash flow less capital expenditures was $320.3 million.
  • Liquidity has improved from late 2022. Cash and equivalents increased from $244.1 million at year-end 2022 to $669.0 million at June 30, 2026. Total current assets of $4.19 billion also exceeded current liabilities of $2.86 billion, producing a current ratio of approximately 1.47.
  • Cash generation is uneven. Operating cash flow was exceptionally strong in Q2 2024 at $798.8 million, but declined to $324.2 million in Q2 2025 before recovering to $490.1 million in Q2 2026. Working-capital changes were a $59.5 million use of cash in the latest quarter, compared with a $332.2 million source of cash in Q3 2025.
  • Capital spending remains substantial. Quarterly purchases of property, plant and equipment have generally ranged from approximately $121 million to $170 million. This spending supports the business but reduces the amount of operating cash available for debt reduction, acquisitions, dividends and repurchases.
  • Leverage has increased and interest costs are rising. Long-term debt increased from $8.60 billion in Q2 2023 to $10.66 billion in Q2 2026, while short-term debt stood at $117.2 million. Quarterly interest expense reached $152.3 million in Q2 2026, up from $111.5 million in Q2 2023, placing pressure on pretax earnings.
  • Common equity is negative. Total common equity declined from $1.02 billion in Q2 2023 to negative $765.1 million at June 30, 2026. Large share repurchases have contributed to treasury stock of negative $787.8 million, and the negative book value means traditional book-value measures are less useful for evaluating the stock.

DaVita’s latest results show a company with stronger revenue, operating margins, EPS and recurring cash generation than it had several years ago. However, the improvement has been accompanied by higher debt, rising interest expense and negative common equity. For investors, the key issues to monitor are whether operating cash flow remains consistently strong enough to reduce leverage and whether future buybacks can continue without weakening the balance sheet further.

11/16/26 02:14 AM ETAI Generated. May Contain Errors.

DaVita Financials - Frequently Asked Questions

According to the most recent income statement we have on file, DaVita's financial year ends in December. Their financial year 2025 ended on December 31, 2025.

DaVita's net income appears to be on an upward trend, with a most recent value of $1.08 billion in 2025, rising from $427.41 million in 2015. The previous period was $1.25 billion in 2024. View DaVita's forecast to see where analysts expect DaVita to go next.

DaVita's total operating income in 2025 was $2.04 billion, based on the following breakdown:
  • Total Gross Profit: $4.40 billion
  • Total Operating Expenses: $2.36 billion

Over the last 10 years, DaVita's total revenue changed from $10.40 billion in 2015 to $13.64 billion in 2025, a change of 31.2%.

In the past 11 quarters, DaVita's cash and equivalents has ranged from $345.13 million in Q1 2024 to $1.07 billion in Q3 2024, and is currently $495.63 million as of their latest financial filing in Q3 2026.

DaVita had total debt of $10.27 billion at the end of 2025, a 8.7% increase from 2024, and a 12.5% increase since 2015.

Over the last 10 years, DaVita's book value per share changed from 23.08 in 2015 to -9.22 in 2025.



Financial statements for NYSE:DVA last updated on 10/29/2026 by MarketBeat.com Staff. New filings and market data are monitored continuously.
From Our Partners